HenRui Pharmaceuticals

Jiangsu Hengrui Pharmaceuticals is a leading global pharmaceutical company based in China, specializing in the research, development, manufacturing, and commercialization of innovative drugs and high-quality generics. The company focuses on several therapeutic areas, including oncology, metabolic diseases, autoimmune disorders, and pain management. Hengrui is well-known for its robust R&D pipeline, featuring a wide array of modalities such as small molecules, monoclonal antibodies, and antibody-drug conjugates. With a significant presence in both domestic and international markets, it has successfully launched numerous innovative products like camrelizumab and fluzoparib. The company continues to expand its global footprint through strategic partnerships and clinical trials worldwide.